Data as of 4:05pm ET
 +0.26 / +9.15%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

CorMedix, Inc. is a development stage pharmaceutical and medical device company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, specifically in the dialysis and non-dialysis areas. The company's products are Neutrolin CRMD003, Thixotropic Gel CRMD004, Deferiprone CRMD001 and Urine Catalytic Test CRMD002. CorMedix was founded on July 28, 2006 and is headquartered in Bridgewater, NJ.

Contact Information

CorMedix, Inc.
745 Route 202-206
Bridgewater New Jersey 08807
P:(908) 517-9500
Investor Relations:
(908) 517-9489



Other institutional14.27%
Individual stakeholders11.21%
Mutual fund holders1.78%

Top Executives

Randy D. MilbyCEO, Director & Head-Media Relations
Harry O'GradyChief Financial Officer
Antony E. PfaffleVice Chairman, Secretary & CSO
William J. VanjonackVice President-Manufacturing & Quality Operations

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.